www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Links  |  Webmaster 
Updated Sun, August 22, 2010.
201.www.vidal.fr20000
202.www.zbmed.de19900
203.www.stronghealth.com19700
204.www.arznei-telegramm.de19700
205.www.brighamandwomens.org19400
206.www.labcorp.com19000
207.www.awfulplasticsurgery.com18800
208.www.kp.org18800
209.www.csmc.edu18700
210.omni.ac.uk18400
211.www.paris-nord-sftg.com18000
212.www.wma.net18000
213.www.medbioworld.com17200
214.www.dialyse-online.de17000
215.www.theheart.org16900
216.www.centromaderna.it16900
217.www.medical-library.org16800
218.www.pasteur-lille.fr16800
219.www.arbeit-und-gesundheit.de16700
220.www.aly-abbara.com16600
221.www.gfmer.ch16400
222.www.oecotrophologie.de16000
223.www.medicina.unibo.it16000
224.www.med.univ-angers.fr15900
225.heartdisease.about.com15800
226.www.biopsychiatry.com15600
227.www.plasticsurgery4u.com15600
228.sportsmedicine.about.com15500
229.www.minervamedica.it15500
230.www.doktoronline.no15400
231.www.hartstichting.nl14700
232.www.uas.se14700
233.www.swedish.org14500
234.www.ivi.es14500
235.medtropoli.net14500
236.www.cancerbacup.org.uk14200
237.www.medlineplus.gov14100
238.www.diseasesdatabase.com14100
239.www.lycaeum.org14000
240.www.urofrance.org13800
241.www.ospfe.it13700
242.bvs.insp.mx13500
243.www.biopsicologia.net13300
244.conganat.uninet.edu13300
245.www.itg.be13200
246.www.todoancianos.com13100
247.www.zahn-online.de12900
248.www.lumc.nl12900
249.www.cc.nih.gov12800
250.www.esculape.com12800
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

242. bvs.insp.mx

Rating: 13500 points*
*amount mentions of word 'bvs.insp.mx' on the other websites

bvs.insp.mx

Biblioteca Virtual en Salud - México

Most popular searches: bvs.insp.mx, Krankenhaus, drug rehab, Cardiac, bvs.inps.mx, bvsinsp.mx, health care, Nachrichten, bvs.inspmx, bv.insp.mx, doctor, bvs.isnp.mx, medicine, medical information, asthma, patient, vaccines, bs.insp.mx, vbs.insp.mx, bsv.insp.mx, drug, bvs.insp.x, bvsi.nsp.mx, , cholesterol, vs.insp.mx, bvs.nsp.mx, physician, family practice, health, Immunology, bvs.ins.mx, bvs.isp.mx, bvs.inspm.x, obesity, blood pressure, genome, Pharmaceutical, bvs.ins.pmx, bv.sinsp.mx, bvs.nisp.mx, bvs.inp.mx, bvs.insp.m, bvs.insp.xm, Allergy, medical research

Google

© 2005-2010 www.Top100Medicine.com
Patients Get Power of Fast Response
A number of incidents have led some hospitals to give patients and families the power to demand immediate attention from experienced medical staff when they fear a worsening condition.
sec.online.wsj.com
FDA Warns on Cigarette Ban
FDA officials warned companies Tuesday to think twice about circumventing a new ban on certain flavored cigarettes by introducing similar products like little cigars.
online.barrons.com
AIDS Vaccine Is of Modest Help
A deeper analysis of the results of an HIV vaccine tested in Thailand suggests that the vaccine may not have been as effective as originally indicated.
online.wsj.com
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'
The Burrill Report submits: By Marie DaghlianChris Viehbacher, CEO of Sanofi-Aventis (SNY), said his company will establish a venture capital fund, joining an ever-growing queue of pharma venture capital funds seeking to gain better access biotech innovation. Viehbacher confirmed the French drugmaker’s plans in comments made at an event at Sanofi’s R&D campus in Cambridge, Massachusetts, the online publication Xconomy reported. The company also announced a significant expansion and extension of its collaboration with Regeneron Pharmaceuticals (REGN). The deal comes a month after Sanofi-Aventis struck a partnership deal with Merrimack Pharmaceuticals focused on the biotech's experimental antibody drug for cancer, and continues Sanofi's strategy of looking outside the company for what Viehbacher calls "right brain activity" that leads to creativity and innovation.Complete Story »
seekingalpha.com
Novartis Bets on Heart Drug
Novartis said it is paying up to $620 million for the world-wide rights to an experimental heart drug in a deal that boosts the Swiss drug maker's portfolio of cardiovascular medicines.
online.wsj.com